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High resolution and high field magnetic resonance neurography (MR neurography, MRN) is shown to have excellent anatomic
capability. There have been considerable advances in the technology in the last few years leading to various feasibility studies using
different structural and functional imaging approaches in both clinical and research settings. This paper is intended to be a useful
seminar for readers who want to gain knowledge of the advancements in the MRN pulse sequences currently used in clinical
practice as well as learn about the other techniques on the horizon aimed at better depiction of nerve anatomy, pathology, and
potential noninvasive evaluation of nerve degeneration or regeneration.
1. Introduction
High resolution and high field (3T) magnetic resonance
neurography (MR neurography, MRN) has been shown to
have excellent anatomic capability. This is in part due to
the rapid improvements in coil technology and software in
the last few years [1–3]. With improved detection of nerve
anatomy and pathology, the value of quantitative functional
MR methods as potential biomarkers in neuromuscular
disease is also being increasingly recognized [4]. While
high resolution 2D (dimensional) and 3D demonstration
of peripheral nerve anatomy and pathology is the current
state of the art, there have been considerable advances in
various aspects of the field leading to successful feasibility
studies employing various structural and functional imaging
techniques in both clinical and research settings [1, 5–7].
This paper is intended to be a useful seminar for readers
who want to gain knowledge of the advancements in the
MRN pulse sequences currently used in clinical practice as
well as learn about the other techniques on the horizon
aimed at better depiction of nerve anatomy, pathology, and
potential noninvasive evaluation of nerve degeneration or
regeneration.
2. Clinical Need for MR Neurography
It is estimated that about 5% of population has some form
of neuropathy, and there is up to 5% incidence of peripheral
nerve injuries in admissions to a level I trauma center [8, 9],
with Sunderland grade I–IV injuries (nerve in continuity) far
more common than the grade V injury (nerve discontinuity).
Clinical evaluation and electrodiagnostic studies provide
incomplete information about the anatomy and degree of
injury. In particular, these studies are not able to differentiate
among grade III–V injuries, which is important from a
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surgical point of view and patient prognosis [10, 11]. Many
of these patients undergo conservative management for 1-2
years depending upon the clinical scenario. One has to often
weigh the benefit versus risk of expectant waiting during this
period being cognizant of the fact that in the unfortunate
event of poor regenerative response and no recovery, the
regional muscles will atrophy and tendon transfers as well
as consequent disability will be the only option left for the
patient with a poor outcome [12]. High field (3 Tesla, T)
imaging employing high resolution MRN techniques is an
important noninvasive modality that can both detect as well
as help to grade nerve injuries [2, 13].
In the clinical arena, there is also an immediate need for
reliable quantitative measures that can evaluate peripheral
nerve regeneration/further degeneration in patients with
traumatic nerve injuries. Proximodistal axonal regeneration
is the leading mechanism of recovery from nerve injuries.
However, it occurs at a slow pace (∼1mm/day), and the
only available clinical tool of “advancing Tinel’s sign” is
often unreliable, subjective, and frequently inaccurate. The
electrodiagnostic studies are also not sufficient due to their
complete dependence on target innervation and lack of
interobserver reliability [12]. Therefore, it is crucial for devel-
opment of a technique that can detect the nerve continuity
or neuroma and can be used serially in a noninvasive
manner to detect the initiation as well as follow the regen-
eration in injured axons proximally and across the injury
site. Another immediate clinical and preclinical need for
noninvasive outcome measurement of nerve regeneration is
in the area of therapeutics aiming to enhance nerve growth in
injuries and mono-/polyneuropathy conditions. Availability
of reliable noninvasive techniques can facilitate clinical trials
using nerve regeneration enhancers (neurotrophic agents),
improvements in the development of nerve conduits with
incorporated molecular biology agents, such as stem cells,
proteins, and nanotechnology [14–16].
3. Three-Dimensional Anatomic Nonselective
MR Neurography
Three-dimensional (3D) anatomic MR imaging is not new
and has been around for more than 2 decades. However,
the latest 3D imaging techniques encompass high resolution
(base resolution > 256 and in plane resolution ∼1mm) with
superior T2 type contrast also available in some sequences.
Additional advanced characteristics include absence of pul-
sation artifacts and isotropic acquisition with multiplanar
capabilities leading to no or only little loss of tissue def-
inition on secondary reformatted images. The addition of
recently developed 3D imaging techniques to standard 2D
MR imaging protocols helps to overcome difficulties such as
imprecise lesion localization, tissue characterization, partial
volume artifacts, and overall image interpretation [1, 4, 13, 17].
These new 3D anatomic MR sequences are now possible
due to increased signal-to-noise ratio (SNR) of the high field
MR scanners, improved coil design and prudent use of paral-
lel imaging techniques. Parallel imaging helps achieve faster
acquisition, increased contrast resolution and/or number of
slices, better background fat suppression, and a reduction
in the echo time/echo spacing, ultimately resulting in less
image distortion [1, 17]. On current 3T MR scanners, 3D
imaging can be quickly obtained within 5-6 minutes depend-
ing upon the field of view and isotropic resolution set in
the range of 0.9–1.5mm. With curved planar reformations
(CPRs) and maximum intensity projections (MIPs), there is
further reduction of noise, and the peripheral nerves can be
beautifully displayed along their long axis to demonstrate
the nerve anatomy and pathology [18]. These sequences are
termed differently by various vendors as SPACE (sampling
perfection with application optimized contrasts using vary-
ing flip angle evolutions, Siemens), Cube (General Electric
Healthcare, Waukesha, WI), and VISTA (Philips, Best, The
Netherlands).The authors use SPACE imaging, which can be
obtained with and without fat suppression and can generate
various contrasts depending upon the clinical situation: T1,
proton density (PD), T2, SPAIR (spectral adiabatic inversion
recovery), and STIR (short tau inversion recovery). The 3D
SPAIR SPACE is used in extremities due to its higher SNR,
3D STIR SPACE is used for plexuses due to better and more
homogeneous fat suppression, and 3D T2 SPACE is used
for spine evaluation (also referred to as MR myelography)
and for the evaluation of preganglionic nerve segments, as
they exit from the spinal cord (Figure 1). Three-dimensional
CISS (constructive interference in steady state) is another
technique available for high resolution cranial nerve and pre-
ganglionic segment evaluation in the background of high-
intensity CSF [19]. While 3D imaging does not currently
replace the 2D imaging (in plane resolution 0.4-0.5mm) for
smaller nerves, it is useful for multiplanar demonstration
of pathology to the referring physicians for presurgical
planning (Figure 2) [13]. The 3D SPAIR SPACE and 3D STIR
SPACE approaches require postprocessing to remove the
hyperintense vessels and fluid containing structures, which
often contaminate the field of view andmay lead to difficulties
in nerve visualization (Figures 3(a) and 3(b)).
4. Three-Dimensional Anatomic
Nerve-Selective MR Neurography
Nerve-selective MR imaging is aimed at suppressing
the vascular and/or fat signal to create unique tissue-
selective images. These are especially useful for radiologists
and referring physicians who are not used to looking at
peripheral nerve images on a routine basis. Such techniques
should be incorporated in the MRN protocol whenever
accurate nerve localization and/or presurgical assessment are
required. There are various ways to create such images, with
all techniques employing some sort of diffusion weighting.
The peripheral nerves have a strong longitudinal order and
orientation of structural components, leading to diffusion
anisotropy. Thus, addition of diffusion weighting (DW)
to the anatomic sequence (hybrid technique), or with
predominant use of a directionally encoded DW sequences,
the technologist can easily generate selective longitudinal
images of the peripheral nerves due to the predominant and
unrestricted longitudinal diffusivity of protons. One such
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Figure 1: (a) 3D anatomic nonselective MRN-MIP reconstruction from a coronal 3D STIR SPACE sequence shows normal symmetric signal
intensity and size of bilateral brachial plexuses (arrows). (b) 3D anatomic nonselective MRN-MIP reconstruction from a coronal 3D STIR
SPACE sequence shows normal symmetric signal intensity and size of bilateral LS plexuses and femoral nerves (arrows). (c) 3D anatomic
nonselective MRN-Axial reconstruction from 3D T2 SPACE sequence shows the dorsal and ventral roots (preganglionic segments) on both
sides (arrows).
(a) (b)
Figure 2: (a) 2D versus 3D anatomic nonselective MRN-Axial T2 SPAIR image through the lower abdomen shows the abnormally
hyperintense left ilioinguinal nerve (arrows) in a suspected case of left ilioinguinal neuropathy. (b) 2D versus 3D anatomic nonselective
MRN-MIP reconstruction from a coronal 3D STIR SPACE sequence barely shows the left ilioinguinal nerve (large arrows). Notice normal
right ilioinguinal nerve (medium arrow) and normal bilateral femoral nerves (small arrows).
technique optimized by the author (AC) and is routinely
used at his institution is fat suppressed 3D DW PSIF
(reversed fast imaging in steady state free precession) due
to its ability to produce nerve specific images with excellent
vascular suppression (inherent low diffusion moment, 𝑏
value ∼80 s/mm2) and fat suppression, while retaining all
the advantages of an isotropic 3D MR imaging technique
(Figure 3(c)). It should be noted that 3D DW PSIF is a
sensitive sequence; it is prone to motion and ghosting arti-
facts. However, MIP reconstructions can enhance apparent
SNR and be used to elegantly demonstrate nerves in multiple
planes (Figure 4) [3, 6, 20]. Since it is a steady state sequence
with both T1 and T2 contrasts, it shows neuropathy and mass
lesions as abnormal T2 hyperintensity, with normal nerves
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Figure 3: (a) Limitation of 3D anatomic nonselective MRN-Axial T2 SPAIR image through the upper calf shows amputation neuromas
of tibial nerve (large arrow) and common peroneal nerve (small arrow). (b) Limitation of 3D anatomic nonselective MRN-Sagittal
reconstruction from a 3D SPAIR SPACE sequence in the same case shows the abnormal tibial nerve in its long axis (smaller arrow) with
an end-bulb neuroma (large arrow). However, there is suboptimal depiction due to hyperintense vascular signal contamination (medium
arrows). (c) 3D anatomic nerve selective MRN-Sagittal reconstruction from a 3D DW PSIF sequence in the same case selectively shows the
abnormal tibial nerve in its long axis (small arrows) with an end-bulb neuroma (large arrow).
Figure 4: 3D anatomic nerve selective MRN-Multiplanar reconstructions from an isotropic 3D DW PSIF sequence through the mid foot
shows the normal long axis appearances of the medial plantar nerve (large arrows) and lateral plantar nerve (small arrow).
appearing isointense to muscles, similar to other anatomic
spin echo type sequences. Additionally, it can also be used
before and after intravenous contrast and has potential to
replace traditional fat suppressed postcontrast T1W imaging.
Selective DW peripheral nerve imaging requires a higher
diffusion moment (𝑏 value ∼400–1200 s/mm2). It can be
performed with a unidirectional motion probing gradient (𝑏
value ∼800 s/mm2) applied in anteroposterior direction in
the axial plane using single shot STIR echo planar imaging.
The perpendicular positioning of the motion probing gradi-
ent to the nerves offers the highest signal as the diffusion is
relatively more restricted across the nerve (Figures 5 and 6)
[21]. Another recently described technique known as SUSHI
(subtraction of unidirectionally encoded images for suppres-
sion of heavily isotropic objects using an intermediate 𝑏
value ∼400–500 s/mm2) depicts the peripheral nerves with
relative selectivity along their long axis by subtracting DW
datasets acquired in directions parallel and perpendicular to
the peripheral nerves using a pair of diffusion sensitizing
gradients [22]. As opposed to diffusion tensor imaging (DTI),
these images maintain relatively higher SNR due to a limited
number of motion probing gradients (less than 3). The
Radiology Research and Practice 5
Figure 5: 3D anatomic nerve selective MRN-Coronal MIP from a
3D diffusion weighted single shot EPI (𝑏 value 800 s/mm2) shows
the symmetrical normal appearance of bilateral brachial plexuses
(arrows).
Figure 6: 3D anatomic nerve selective MRN-Coronal MIP from a
3Ddiffusionweighted single shot EPI (𝑏 value 800 s/mm2) shows the
peripheral nerve sheath tumors originating from the right C5 nerve
root and the left upper trunk (arrows).
acquired data can be reconstructed using thick slab MIPs
followed by grey scale window setting inversion to selectively
depict the long trajectory of the nerves with decreased noise
conspicuity.TheMIPs are best performed using a soap bubble
technique (Philips Healthcare) that uses a curved subvolume
data set [21, 22], which helps exclude overlapping structures.
Although this method is useful for selective nerve depiction,
we prefer 3D anatomic and hybrid 3D DW PSIF images over
DW imaging as these are better for fascicular evaluation and
regional neuromuscular assessment due to the higher SNR
and resolution available on these techniques. Additionally,
pre-ganglionic nerve segment assessment as well as evalua-
tion of the nerves running parallel to themotion probing gra-
dient are difficult to perform on DW imaging. Finally, bones
and lymph nodes show up as high signal on DW imaging and
vessel contaminationmay still be present, leading to difficulty
in nerve visualization, especially in the distal calf.
5. Three-Dimensional (3D) Functional Nerve
Selective Imaging
The anatomic techniques are good for the assessment of
neuropathy and worsening axonal degeneration; however, T2
signal alterations are not proven to reliably assess the nerve
regeneration after traumatic injuries or nerve surgery [24–
26]. The need for more objective and noninvasive functional
measures of axonal regeneration in peripheral nerves is
increasingly recognized as new therapeutic targets are being
explored and many novel interventions are entering the
preclinical stage of drug development. Three-dimensional
(3D) functional nerve selective imaging can be performed
using diffusion tensor imaging (DTI), and results from initial
feasibility studies are becoming available [27–29].
DTI interrogates the random thermal motion of water
molecules within tissues along different axes. It can therefore
be used to exploit the potential of distinct microstructural
properties of the peripheral nerves that hinder proton diffu-
sion in some directions and facilitate it in other directions.
DTI thus allows interrogation of the microarchitecture of
the nerves, which is beyond the resolution of anatomic
imaging techniques.This technique has proven clinical utility
in a number of brain and spinal cord studies. However,
early feasibility data from peripheral nerve are becoming
available in the last few years with encouraging results in
carpal tunnel studies in humans and sciatic nerve stud-
ies in animals [5, 27–29]. Generally, 6 or more diffusion
encoding directions are required for DTI and commonly
12–20 directions and several 𝑏 values (commonly 0, 500,
1000 s/mm2) are used to obtain improved diffusion tensor
maps. However, this may result in significantly reduced SNR
(Figure 7). Poor fat saturation, image distortions, as well as
eddy current and ghosting artifacts may limit image quality.
Additionally, acquisition times increase predisposing the
imaging tomotion artifacts.Three Tesla imagingwith parallel
acquisition, imaging in the axial plane, and tighter echo
spacing enable highly resolved tensor maps. For peripheral
nerves, higher 𝑏 values in the range of 800–1000 s/mm2
and for plexuses, lower b values in the range of 600–
800 s/mm2 generally produce adequate SNR and good quality
datasets (Figure 8) [30]. However, the choice of the 𝑏 value
ultimately depends on the field strength, coil, and receiver
technology.
DTI not only allows selective nerve visualization, but also
enables quantitative measurement by creation of tractogra-
phymaps.Themeasurements are fitted to a 3Ddiffusion ellip-
soid tensor model [31, 32] which allows calculation of several
semiquantitative parameters including the apparent diffusion
coefficient (ADC) and fractional anisotropy (FA). ADC is a
scalar value that reflects molecular diffusivity under motion
restriction, and FA characterizes the directional variability
in the diffusion, with an FA value of 0 representing random
isotropic diffusion and 1 representing complete anisotropy.
Fiber tractography can be performed with a line propagation
technique (linear tracking algorithm) in which a tracking line
is propagated from a start point (seed) placed perpendicular
to the nerve in the principal diffusion direction.This method
excludes the other false positive trajectories that may arise
from anisotropic structures, such as the skeletal muscles. DTI
can be used to evaluate fiber density by displaying tracts on
color-coded 3D images [28].
Normal nerve FA values range from 0.4–0.8 depending
on the SNR and type of nerve. However, the mean values of
the normal nerves under interrogation are generally within
2 standard deviations of the adjacent nerves or contralateral
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Figure 7: 3D functional nerve selective MRN-Coronal MIP
(inverted grey scale contrast) from a 3DDTI using single shot EPI (𝑏
value 0, 800, 1000 s/mm2 and 12 directions of interrogation) shows
the symmetrical normal appearance of bilateral brachial plexuses
(arrows). However, notice the decrease in SNR as compared to
diffusion weighted imaging as shown in Figure 5.
equivalent nerves, and significant reductions of FA in abnor-
mal nerves have been observed [27, 31]. Increased diffusivity,
measured using the ADC, generally reflects inflammation,
edema, or expanded nerve space, whereas decreased FA
may be caused by damaged tissue microstructure, axonal
loss and/or demyelination, or increase in isotropic water
volume. Therefore, decreasing FA values is expected with
worsening neuropathy. In a study by Takagi et al., the FA
values decreased at the site of injury immediately following
the insult and distally along the nerve 4 days after the injury.
Additionally, increased FA values were observed at 3 weeks
after injury correlating with functional motor and sensory
recovery as well as nerve regeneration [7]. The previous
authors found that the FA alterations of the peripheral
nerves weremore strongly correlatedwith axon-related (axon
density and diameter) than with myelin-related (myelin
density and thickness) parameters, supporting the theory that
axonal membranes play a major role in anisotropic water
diffusion and that myelination can modulate the degree of
anisotropy. Tractography based on FA values also showed
loss of fiber tracking distal to the crush site at earlier time
points, and recovery of fiber tracking was noted at later
time points related to axonal regeneration. In another sciatic
nerve crush model, Lehmann et al. also found that FA
values are a more useful parameter than diffusivity in the
assessment of axonal regeneration [33]. In a recent carpal
tunnel syndrome (CTS) case-control study, the FA, radial
diffusivity, and ADC differed significantly between healthy
subjects and CTS patients. DTI indices differed in regions
proximal to and within the carpal tunnel in a manner which
seemed to appropriately reflect pathophysiology of CTS [34].
ADC values also help differentiate among benign and
malignant tumors. Higher ADC values are seen with
benign peripheral nerve sheath tumors and other soft tissue
tumors (1.1–2.0 × 10−3mm2/s), while low diffusivity values
(0.7–1.0 × 10−3mm2/s) are seen in malignant lesions (Fig-
ure 9) [35]. We presently use 3 cutoffs for their clinical prac-
tice currently (ADC—< 1.0 × 10−3mm2/s—suspicious for
malignancy, ADC—1.0–1.5 × 10−3mm2/s—indeterminate,
ADC—> 1.5 × 10−3mm2/s—usually benign.) However, the
ADC values should complement the conventional imaging
appearances of these lesions, and one should not read them
in isolation. Secondly, the reader should focus on the lowest
Figure 8: 3D functional nerve selective MRN-Coronal MIP
(inverted grey scale contrast) from a 3D DTI using single shot EPI
(𝑏 values 0, 600 s/mm2 and 20 directions of interrogation) shows the
symmetrical enlargement of bilateral LS plexus nerve roots (arrows)
in a known case of hereditary motor and sensory neuropathy with
diffusely reduced FA values in bilateral nerves.
ADC of the lesion, which correlates with the cellularity of
the lesion, since even malignant lesions can have higher
ADC values in their necrotic/less cellular portions. The
lower ADC areas also correlate with the highest F18 FDG
PET uptake regions and solid nodular arterial enhancing
areas of the tumors, which helps in locating the most
cellular areas for biopsy (Figure 10). It should also be kept
in mind that interval measurements over time are more
useful than a one-time measurement. This helps to follow
the lesions, while patient is on medical treatment, such as
imatinib. Increasing ADC values generally correlates with
tumor response; however, it remains to be seen if they add
more value over contrast imaging. But, as initial results
are becoming available, MRN with DTI promises to be a
single shot modality for the evaluation of peripheral nerve
sheath tumors. Finally, tractography provides another insight
into the pathophysiologic mechanisms of the lesions arising
within or in close relationship to the directionally ordered
nerve fibers. The degree of nerve tract disruption potentially
correlates with increased aggressiveness/malignancy of the
lesion and gives the surgeon an idea about potential fascicular
infiltration of the tumor cells and difficulty in resection,
which can be foreseen before the operation and is currently
beyond the capability of anatomic images [1, 28].
DTI provides a unique opportunity to evaluate the
complex diffusion patterns that occur within the nerve and
allows understanding of pathophysiologic mechanisms in a
3Dmanner although some limitations need to be understood.
DTI is a sensitive sequence, prone to motion and ghosting
artifacts. Although peripheral nerves have a simpler archi-
tecture than the central nervous system and tractography
should be easier to perform, DTI usually suffers from the
relatively short T2 of water protons in the nerves leading to
poor SNR.The variations in image quality or DTI parameters
may significantly degrade serial assessment of parametric
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Figure 9: (a) Combined anatomic and functional MRN-MIP reconstruction from a 3D STIR SPACE sequence shows abnormal fusiform
enlargement of the right S1 nerve root by a benign peripheral nerve sheath tumor (large arrows). Notice the normal appearance of the
contralateral S1 nerve root (small arrow). (b) Combined anatomic and functional MRN-ADC map from single shot EPI DTI (𝑏 value 0,
600 s/mm2 and 20 directions) sequence shows highADCvalue (1.4×10−3mm2/s). (c) Combined anatomic and functionalMRN-Tractography
map following tensor calculation from single shot EPI DTI sequence shows nearly normal tracts (arrow) through the mass lesion in keeping
with benign nature of the lesion.
(a) (b) (c)
Figure 10: (a) Anatomic MRN, functional MRN, and F-18 FDG-PET correlation-Coronal fat suppressed postcontrast 3D T1W image of a
biopsy proven malignant peripheral nerve sheath tumor shows the solid heterogeneous enhancement along the superior aspect of the lesion
(large arrow). Notice additional smaller benign PNSTs in this case of neurofibromatosis type I (small arrows). (b) AnatomicMRN, functional
MRN, and F-18 FDG-PET correlation-Coronal MIP reconstruction (inverted grey scale contrast) from single shot DTI (𝑏 values 0, 800,
1000 s/mm2, 12 directions) image shows the lowest ADC values (0.7×10−3mm2/s) along the superior aspect of the lesion, which was targeted
for the successful biopsy (large arrow). Notice that the additional smaller benign PNSTs showhigher ADCvalues (small arrows). (c) Anatomic
MRN, functional MRN, and F-18 FDG-PET correlation-Coronal F-18 FDG image shows high SUV max value (4 increased to 6 on delayed
image) in the corresponding superior aspect of the lesion.
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values and tensor maps. Maintaining the same acquisition
parameters on serial scans, the application of good uniform
fat suppression (water selective/Dixon/STIR), parallel imag-
ing, keeping the slice thickness at or above 4mm, employing
higher strength gradients, lower echo times, and tighter
echo spacing each help to generate acceptable images with
adequate spatial resolution and reproducible tractography.
The reader should understand that DTI is still at a feasibility
assessment stage and is limited by relative lack of stan-
dardization and complexity of post-processing techniques.
The preliminary ADC and FA data among different subjects
show high (274%) variability. However, one could use healthy
contralateral nerve as an internal control, since there is
absence of statistically significant intrasubject side-to-side
variability in quantitative data [29].
Fixed points of measurements based on bony landmarks
should be used for quantitative measurements to mitigate
variability, and the applied regions of interest should be
small to avoid partial volume artifacts and large enough to
cover the representative area of the nerve. Finally, the reader
should understand that axonal loss injury also results in
myelin loss over time, and the exact relative contributions
of the two pathological conditions to the DTI parameters
measured are not clearly known. With future research, DTI
will likely play an important role in the evaluation and further
understanding of neuromuscular diseases and is expected
to be an important complement to current anatomic MRN
protocols.
6. Magnetization Transfer (MT) Imaging
MT imaging provides information about in vivo tissue
integrity by exploiting differences in the properties of free
water protons and restricted protons that are bound to
macromolecules, proteins, and cell membranes. The bound
protons in peripheral nerve include collagen, myelin, and
membranes contained in the nerve fibers.The bound protons
have a T2 relaxation time too short to be detected by conven-
tional MR imaging techniques. However, MT imaging offers
indirect characterization of the bound proton component
and might provide information about nerve damage and
demyelination in peripheral neuropathy. Selective saturation
of the bound pool can be achieved with an applied off
resonance radiofrequency pulse and when combined with
a 3D spoiled gradient-echo image readout may be used to
generate additional contrast on conventionalMR images.The
semiquantitative MT ratio (MTR) may also be calculated by
comparing the signal reduction of an MT-weighted image
relative to an image without MT saturation [36].
In isotropic fluid compartments such as the cerebrospinal
fluid (CSF), where a negligible concentration of macro-
molecules is present, the MTR is close to zero. In studies
of multiple sclerosis, a decrease of MTR baseline values
has been observed to correlate with demyelination, edema,
and/or tissue damage in the brain [37]. In a study of optic
neuropathy, MTR was reduced in affected nerves compared
to clinically unaffected nerves [23]. Retinal neuroaxonal loss
also correlated with MTR. Since axonal loss following optic
neuritis also results in myelin loss, the relative contributions
of the two pathological conditions to the MTR measures
could not be evaluated. In a recent study of healthy volunteers,
Gambarota et al. observed significant differences in the MTR
of foot nerves versus median nerves; however, the regional
muscles showed no significant differences [36]. MT imaging
of muscle tissue has shown promise in neuropathic diseases
including diabetic foot neuropathy, chronic inflammatory
demyelinating polyneuropathy (CIDP), and Charcot Marie
Tooth (CMT) disease (Figure 11), where decreased MTR is
observed in muscles affected by these diseases as well as in
muscle conditions including limb girdle muscular dystrophy
[23, 38–41]. More research on MT imaging in peripheral
neuropathy is needed, and its value for evaluation of muscle
denervation compared with STIR and DW imaging needs to
be proven before it can be used in the routine clinical setting.
MT imaging has limitations that include a typically high
sequence specific absorption rate (SAR) and a dependence of
the measured MTR values on the specific sequence param-
eters used. Quantitative measurements in nerve present a
particular challenge because of the requirement for high
spatial resolution and SNR.
7. Muscle Imaging
MR can demonstrate regional muscle denervation changes
in addition to the direct signs of nerve abnormality. These
muscle findings evolve from edema like signal on fat sup-
pressed T2WMR images in acute stages to fatty replacement
and atrophywith chronicity [18, 42]. Although the prognostic
factors affecting the outcome of nerve repair vary depending
upon the degree of nerve injury and other clinical factors,
such as age, patient’s expectation, and surgeon’s experience,
fatty replacement and atrophy of the regional muscles is one
of the important and measurable factors negatively influenc-
ing functional and anatomic outcomes [12, 43]. In addition to
DTI and MT imaging mentioned earlier, a number of other
functional MR imaging tools are available for assessment of
regional muscle architecture and perfusion such as MR spec-
troscopy (MRS), C13 hyperpolarized imaging, or multiecho
imaging for fat fraction assessment, chemical shift imaging
(CSI), as well as ASL (arterial spin labeling) andBOLD (blood
level oxygenation determination) imaging. Research is under
way using these technologies at various centers looking at
different functional and pathophysiologic mechanisms of
the neuromuscular disease [44–48]. Despite the advantage
of MR imaging in detecting muscle morphology changes,
biochemistry, and pathology combined with the potential to
influence the way surgeons approach and treat nerve injury
patients, there is currently paucity of research or literature on
this subject on how it would affect clinical decision making.
8. Whole Body MRN
Whole body MR imaging has been around for many years
for the evaluation of metastatic disease, myeloma, and lym-
phoma. Takahara et al. described a free breathing DW whole
body MR imaging technique with background body signal
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Figure 11: (a) MT neurography imaging of the sciatic nerve- Magnetization transfer ratio map at the mid-thigh level. Inset: enlargement of
the sciatic nerve demonstrates measurable MTR effect in the nerve. (b) MTmuscle imaging of neuropathy. Magnetization transfer ratio map
of the mid-calf muscles of a patient with Charcot-Marie-Tooth disease type 1A (CMT1A).TheMTR is reduced in areas affected by pathology.
The maps have been corrected for RF inhomogeneities with a compensation method using B1 transmit maps [23].
suppression and an STIR prepulse for robust fat suppression,
which enables a longer effective imaging time than that with
breath-hold imaging and allows acquisition of a large number
of thin sections and three-dimensional analyses.This allowed
signal decrease from intravoxel incoherent motion and not
from respiratory motion (coherent motion) during the short
time (approximately 100ms) that motion-probing gradients
are applied [49].Whole bodyMR imaging using 3D isotropic
STIR SPACE is also being performed with success at our
institute [50]. Whole body MRN using simple diffusion
weighted imaging was reported by Yamashita et al. in 2009
[51]. However, using a combination of thin collimation
(1.5mm isotropic) high contrast 3D STIR SPACE and DTI,
whole body MRN can be performed in acceptable time
periods of less than 45min to 1 hour by employing parallel
imaging technique (iPat factor: 2–4) with coverage from
the skull base to the level of the knees in our preliminary
experience, and feasibility studies are being performed using
this technology (Figure 12). Adding DTI of the plexuses to
the anatomic imaging represents a considerable advance in
imaging and holds promise in assessment of disease burden
and treatment response in neurocutaneous syndromes,
CIDP, and hereditary neuropathies, such as CMT disease.
This technique allows thin section reconstruction in any
desired plane, avoids partial volume artifacts, and can easily
detect thickened nerves or related mass lesions. Additionally,
DTI of plexuses may be used for functional evaluation, and
similar techniques could be used for followups on treatment
or on finding worsening neuropathy.
9. Contrast Agents and Other Imaging Agents
The application of intravenous gadolinium-based contrast
agents is currently limited in MRN studies to examinations
performed for indications of infection, inflammation and
neoplastic conditions (Figure 10) [2, 13, 20, 26]. Two different
exogeneous intravenous contrast agents have been tried
in evaluation of peripheral neuropathy. These include
superparamagnetic iron oxide (SPIO) and gadoflouride M
[52–54]. Gadoflouride M (GFM) is a nerve-selective contrast
agent, which in animal studies has been shown to accumulate
in nerve fibers undergoing Wallerian degeneration and
disappear with remyelination. However, GFM has to
undergo various research trials and human safety testing
before it can receive FDA approval or can be used in clinical
setting. Additionally, difficulty in visualizing axons makes
these methods impractical for evaluating peripheral nerve
injury in the present clinical scenario. Finally, molecular
agents, such as stem cells, proteins, and nanoparticles
under development can be potentially infused to selectively
enhance/image nerve regeneration and hold considerable
promise in the advancement of the field [14–16, 55].
10. Testing the Significance of Nerve
Abnormality Causing Symptoms
There are various ways to test whether the nerve itself
or an associated imaging abnormality such as neuroma is
the potential cause of patient symptoms. This could be
done by ultrasound guided (USG) injections for super-
ficial nerves and MR guided injection for the deeply
located/nonidentifiable nerves on other imaging techniques
(Figure 13). Although image guided injections have high face
validity and are good for therapeutic effect, any diagnostic
injection should ideally follow a protocol of comparative,
graded, or placebo controlled injections to be accurate and
valid [56, 57]. Another tool that may become available in
future is high intensity focused ultrasound, which is shown to
reliably induce sensations in human test subjects in a manner
that correlates with their mechanoreceptor density [58].
11. Teaching and Web Tools
With excellent imaging of peripheral nerve anatomy and
pathology available with current techniques and functional
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Figure 12: (a), (b) Whole body MRN: Coronal MIP reconstructions from 3D STIR SPACE sequence ((a) conventional window setting; (b)
inverted window setting) show the normal appearance of bilateral brachial plexus (large arrows), LS plexus (medium arrows), and sciatic
nerves (small arrows). (c), (d) Whole bodyMRN: Coronal MIP reconstructions (inverted grey scale contrast) from single shot DTI sequence
(𝑏 values 0, 600 s/mm2, 20 directions) of the brachial plexus (c) and LS plexus (d).
evaluation becoming possible, it is important for the radi-
ologist to gain knowledge of the complex peripheral ner-
vous system anatomy and its normal as well as abnormal
imaging appearances. Also, with widespread use of high-
resolution MRN imaging, various small and large nerve
branches can be visualized. An experienced observer can
easily find them; however, the complex anatomy can be
difficult to navigate through for those not used to looking
at these tiny peripheral branches. Existing illustrations are
limited in their effectiveness due to previous technology,
illustration technique, and limitations of education media.
Increasingly, text books and journals are being replaced by
digital interactive media. For this reason, it is important to
superimpose anatomic illustrations over the MRN images
and develop a digital platform for their demonstration to keep
in stride with the advancements of science and education.
With tandem depiction of sequential axial 2D MRN and 3D
MRN images and original custom illustrated images with
nerve labeling, the entirety of the peripheral nerve can be
illustrated. Once integrated with the web tools, a reader
can use them for their learning, correct nerve identification
and MRN interpretation (Figure 14). Such an idea has been
envisioned by the authors, and it is conceivable that it will
likely become a useful web tool in few years to come.
12. Nerve Segmentation
Although appropriate performance of MRN using 3D imag-
ing and the correct interpretation of the nerve findings is
Radiology Research and Practice 11
(a) (b)
(c) (d)
Figure 13: (a)–(d) MRN guided intervention-Axial T2 SPAIR (a), PDW (b), STIR (c), and T2 SPACE (d) images obtained during injection
of local anesthetic and steroid combination around the right ilioinguinal nerve (arrow in a), beneath the external oblique aponeurosis. The
patient experienced no significant pain relief following the injection in keeping with a negative block.
Figure 14: Anatomic illustration usingMRN-Axial T2 SPAIR image
through the upper pelvis with color drawing overlay nicely depicting
the pelvic neuromuscular anatomy.
essential, it is also important to display the nerve anatomy
and pathology to surgeons in a longitudinal manner, as they
are used to seeing them during surgical dissection. Nerve
segmentation allows longitudinal depiction of the peripheral
nerves in multiple planes but also avoids contamination from
the adjacent bright vessels and displays nerve architectural
variations (bifid, trifid, or split). Most readers use axial
images for primary detailed assessment of the nerves. A
tool which can reconstruct the nerves in longitudinal planes
by placing the regions of interest on the axial images,
where these are best and reliably identified, would also
help solve the issues encountered in the nerve identifica-
tion, and depiction along its long axis and help diagnosis
of displacement/entrapment/impingement by demonstrating
alterations in the course as well as caliber of the nerves. Cus-
tom made software such as “Nerve Vision” will be available
in future, which allows DICOM image import as well as
navigation by implementing a semi-automatic segmentation
algorithm consisting of two main steps. First, the user starts
the segmentation of the object by interactively placing few
control points at the nerve’s border (not necessarily located
on local maximal or most significant gradients). Second,
these points are connected to an initial polygonal contour
consisting of an order set of vertices. The algorithm then
evolves a 3D polygonal contour that is as similar as possible
to the landmarks in its behavior. In addition to the image-
based attributes, the algorithm maintains the smoothness of
the contour throughout the course of the nerve to ensure
robust segmentation results. Additionally, in order to help the
user best understand the volume data and to uncover impor-
tant details in the volume data, the software implements a
real-time visualization method based on GPU ray casting,
which is capable of using multiple planes for convex volume
clipping. This approach allows the user to select arbitrary
number of clipping planes. This novel approach to 3D nerve
segmentation of the peripheral nerves in the axial planes
using semiautomated interactive algorithmsprovides realistic
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Figure 15: Nerve segmentation-Median nerve segmentation using custom made software. The tool allows semiautomated nerve
segmentation, while a user draws region of interest on the nerve on sequential axial images.
3D visualization of the long axis of the nerve. This can be
useful for identification, visualization of position, and for
finding displacement/impingement and caliber variations of
the nerve, as well as to track the nerve propagation through
the confined spaces (tunnels) (Figure 15).
To conclude, there have been considerable advances in
the field of MR neurography making it a fruitful area for
researchers to exploit the potential of a range of techniques
currently available for imaging nerve and regionalmuscle and
to assess their function in both research and clinical settings.
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